肠道菌群
微生物群
生物
肠道微生物群
平衡
胰岛素抵抗
糖尿病
葡萄糖稳态
疾病
免疫学
2型糖尿病
生物信息学
内分泌学
内科学
医学
作者
Elizabeth Howard,Tony K.T. Lam,Frank A. Duca
出处
期刊:Annual Review of Medicine
[Annual Reviews]
日期:2022-01-27
卷期号:73 (1): 469-481
被引量:16
标识
DOI:10.1146/annurev-med-042220-012821
摘要
Type 2 diabetes rates continue to rise unabated, underscoring the need to better understand the etiology and potential therapeutic options available for this disease. The gut microbiome plays a role in glucose homeostasis, and diabetes is associated with alterations in the gut microbiome. Given that consumption of a Western diet is associated with increased metabolic disease, and that a Western diet alters the gut microbiome, it is plausible that changes in the gut microbiota mediate the dysregulation in glucose homeostasis. In this review, we highlight a few of the most significant mechanisms by which the gut microbiome can influence glucose regulation, including changes in gut permeability, gut-brain signaling, and production of bacteria-derived metabolites like short-chain fatty acids and bile acids. A better understanding of these pathways could lead to the development of novel therapeutics to target the gut microbiome in order to restore glucose homeostasis in metabolic disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI